FindTrial
Sign In

A study of painkiller property of liquid ghee in migraine through nasya (nasal drop therapy).

A study of Shirashoolghna property of Ghrutmanda in Ardhavabhedak by Pratimarsha-nasya with special reference to "Nasya-Karma Siddhanta".

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/07/026768
Enrollment
50
Registered
2020-07-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G892- Chronic pain, not elsewhere classified

Interventions

Intervention1: Ghrutmanda: administration of Ghrutmanda by pratimarsha nasya or 2 nasal drops BD for 14 days Control Intervention1: Not Applicable: Not Applicable

Sponsors

SSAM
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients between age group of 18 to 60 of both genders. 2) Patients suffering from Ardhavabhedak or having history of episodes.

Exclusion criteria

Exclusion criteria: 1) Patients suffering from Head injury. 2) Patients suffering from any severe conditions where Shirashool is manifested as a symptom (Brain tumor, encephalitis, brain aneurysm, brain AVM, glaucoma, severe sinusitis, Poisoning, Ear infection, Myocardial Infarction).

Design outcomes

Primary

MeasureTime frame
To evaluate to shirashoolghna property of GhrutmandaTimepoint: outcome will be assessed at 7th and 14th day.—

Secondary

MeasureTime frame
noneTimepoint: none—

Countries

India

Contacts

Public ContactShaunak Vivek Sane

MAMs Sumatibhai Shah Ayurved Mahavidyalaya

saneshaunak@gmail.com7620031132

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026